{
    "level": 0,
    "name": "Hypertension",
    "UMary": [
        {
            "id": 0,
            "Mval": 0,
            "domARY": []
        },
        {
            "id": 1,
            "Mval": 27,
            "domARY": [
                {
                    "id": 12,
                    "innerText": "流行病學 (Epidemiology)",
                    "prevID": 11,
                    "parrentID": 11,
                    "prevsiblingID": null
                },
                {
                    "id": 21,
                    "innerText": "依據 2022 台灣高血壓指引，診斷高血壓需多次量測血壓，確認數值：",
                    "prevID": 20,
                    "parrentID": 20,
                    "prevsiblingID": 12
                },
                {
                    "id": 24,
                    "innerText": "典型症狀",
                    "prevID": 23,
                    "parrentID": 23,
                    "prevsiblingID": 21
                },
                {
                    "id": 27,
                    "innerText": "病生理 (Pathophysiology)",
                    "prevID": 26,
                    "parrentID": 26,
                    "prevsiblingID": 24
                },
                {
                    "id": 37,
                    "innerText": "病因分類",
                    "prevID": 36,
                    "parrentID": 36,
                    "prevsiblingID": 27
                },
                {
                    "id": 48,
                    "innerText": " ",
                    "prevID": 47,
                    "parrentID": 47,
                    "prevsiblingID": 37
                },
                {
                    "id": 49,
                    "innerText": "特殊型高血壓",
                    "prevID": 48,
                    "parrentID": 48,
                    "prevsiblingID": 48
                },
                {
                    "id": 61,
                    "innerText": "病生理 (Pathophysiology)",
                    "prevID": 60,
                    "parrentID": 60,
                    "prevsiblingID": 49
                },
                {
                    "id": 72,
                    "innerText": "高血壓對各器官的併發症與機制",
                    "prevID": 71,
                    "parrentID": 71,
                    "prevsiblingID": 61
                },
                {
                    "id": 75,
                    "innerText": "高血壓危象（Hypertensive Crisis）",
                    "prevID": 74,
                    "parrentID": 74,
                    "prevsiblingID": 72
                },
                {
                    "id": 77,
                    "innerText": " ",
                    "prevID": 76,
                    "parrentID": 76,
                    "prevsiblingID": 75
                },
                {
                    "id": 78,
                    "innerText": "高血壓治療目標",
                    "prevID": 77,
                    "parrentID": 77,
                    "prevsiblingID": 77
                },
                {
                    "id": 80,
                    "innerText": "老年人降壓需謹慎，避免過度降壓導致低血壓或跌倒。",
                    "prevID": 79,
                    "parrentID": 79,
                    "prevsiblingID": 78
                },
                {
                    "id": 81,
                    "innerText": " ",
                    "prevID": 80,
                    "parrentID": 80,
                    "prevsiblingID": 80
                },
                {
                    "id": 82,
                    "innerText": "高血壓治療策略",
                    "prevID": 81,
                    "parrentID": 81,
                    "prevsiblingID": 81
                },
                {
                    "id": 87,
                    "innerText": "第一線降壓藥物（適用大部分患者）：",
                    "prevID": 86,
                    "parrentID": 86,
                    "prevsiblingID": 82
                },
                {
                    "id": 89,
                    "innerText": "第二線降壓藥物（合併特殊疾病）：",
                    "prevID": 88,
                    "parrentID": 88,
                    "prevsiblingID": 87
                },
                {
                    "id": 91,
                    "innerText": "藥物合併原則",
                    "prevID": 90,
                    "parrentID": 90,
                    "prevsiblingID": 89
                },
                {
                    "id": 95,
                    "innerText": "\n ",
                    "prevID": 94,
                    "parrentID": 94,
                    "prevsiblingID": 91
                },
                {
                    "id": 96,
                    "innerText": "常見降壓藥物（IV 用藥）",
                    "prevID": 95,
                    "parrentID": 95,
                    "prevsiblingID": 95
                },
                {
                    "id": 98,
                    "innerText": "補充考試重點",
                    "prevID": 97,
                    "parrentID": 97,
                    "prevsiblingID": 96
                }
            ]
        },
        {
            "id": 2,
            "Mval": 54,
            "domARY": [
                {
                    "id": 13,
                    "innerText": "全球影響：",
                    "prevID": 12,
                    "parrentID": 12,
                    "prevsiblingID": null
                },
                {
                    "id": 17,
                    "innerText": "台灣現況：",
                    "prevID": 16,
                    "parrentID": 16,
                    "prevsiblingID": 13
                },
                {
                    "id": 25,
                    "innerText": "早期無症狀，因此高血壓常被稱為 「沉默的殺手 (Silent Killer)」。",
                    "prevID": 24,
                    "parrentID": 24,
                    "prevsiblingID": 17
                },
                {
                    "id": 26,
                    "innerText": "症狀出現時通常已影響器官，可能表現為：頭痛、頭暈、耳鳴、視力模糊 (視網膜血管受損)、心悸、胸悶 (心血管受影響)、下肢水腫 (腎臟受影響)。",
                    "prevID": 25,
                    "parrentID": 25,
                    "prevsiblingID": 25
                },
                {
                    "id": 28,
                    "innerText": "血壓調節機制",
                    "prevID": 27,
                    "parrentID": 27,
                    "prevsiblingID": 26
                },
                {
                    "id": 38,
                    "innerText": "原發性高血壓 (Essential HTN）",
                    "prevID": 37,
                    "parrentID": 37,
                    "prevsiblingID": 28
                },
                {
                    "id": 44,
                    "innerText": "次發性高血壓（Secondary HTN）",
                    "prevID": 43,
                    "parrentID": 43,
                    "prevsiblingID": 38
                },
                {
                    "id": 46,
                    "innerText": "次發性高血壓主要病因：",
                    "prevID": 45,
                    "parrentID": 45,
                    "prevsiblingID": 44
                },
                {
                    "id": 50,
                    "innerText": "隱藏性高血壓（Masked Hypertension）",
                    "prevID": 49,
                    "parrentID": 49,
                    "prevsiblingID": 46
                },
                {
                    "id": 54,
                    "innerText": "白袍高血壓（White Coat Hypertension）",
                    "prevID": 53,
                    "parrentID": 53,
                    "prevsiblingID": 50
                },
                {
                    "id": 58,
                    "innerText": "抵抗性高血壓（Resistant Hypertension）",
                    "prevID": 57,
                    "parrentID": 57,
                    "prevsiblingID": 54
                },
                {
                    "id": 62,
                    "innerText": "血壓調節機制",
                    "prevID": 61,
                    "parrentID": 61,
                    "prevsiblingID": 58
                },
                {
                    "id": 83,
                    "innerText": "生活型態調整（適用所有高血壓患者）",
                    "prevID": 82,
                    "parrentID": 82,
                    "prevsiblingID": 62
                },
                {
                    "id": 86,
                    "innerText": "藥物治療選擇",
                    "prevID": 85,
                    "parrentID": 85,
                    "prevsiblingID": 83
                },
                {
                    "id": 92,
                    "innerText": "Stage 1 HTN（130-139/80-89） → 生活方式調整 + 單一藥物（ACEI, ARB, CCB, Thiazide）。",
                    "prevID": 91,
                    "parrentID": 91,
                    "prevsiblingID": 86
                },
                {
                    "id": 93,
                    "innerText": "Stage 2 HTN（≥140/90） → 直接合併2種藥物（如 ACEI/ARB + CCB 或 Thiazide）。",
                    "prevID": 92,
                    "parrentID": 92,
                    "prevsiblingID": 92
                },
                {
                    "id": 94,
                    "innerText": "若目標未達成（≥ 130/80） → 增加藥物劑量或加第三種藥物。",
                    "prevID": 93,
                    "parrentID": 93,
                    "prevsiblingID": 93
                },
                {
                    "id": 99,
                    "innerText": "惡性高血壓（Malignant Hypertension）：臨床上常用於指合併視乳頭水腫（papilledema）的高血壓危象",
                    "prevID": 98,
                    "parrentID": 98,
                    "prevsiblingID": 94
                },
                {
                    "id": 100,
                    "innerText": "高血壓危象治療關鍵：降壓速度需逐步降低，不可過快，否則會導致器官低灌流，如腦中風、心肌梗塞",
                    "prevID": 99,
                    "parrentID": 99,
                    "prevsiblingID": 99
                },
                {
                    "id": 101,
                    "innerText": "視網膜變化：視網膜出血、視乳頭水腫，嚴重時可致盲",
                    "prevID": 100,
                    "parrentID": 100,
                    "prevsiblingID": 100
                },
                {
                    "id": 102,
                    "innerText": "神經學表現：高血壓腦病變（hypertensive encephalopathy），症狀如意識改變、癲癇",
                    "prevID": 101,
                    "parrentID": 101,
                    "prevsiblingID": 101
                },
                {
                    "id": 103,
                    "innerText": " ",
                    "prevID": 102,
                    "parrentID": 102,
                    "prevsiblingID": 102
                },
                {
                    "id": 104,
                    "innerText": "REFERENCE：",
                    "prevID": 103,
                    "parrentID": 103,
                    "prevsiblingID": 103
                },
                {
                    "id": 105,
                    "innerText": "HARRISON Principles of Internal Medicine 20th Edition",
                    "prevID": 104,
                    "parrentID": 104,
                    "prevsiblingID": 104
                },
                {
                    "id": 106,
                    "innerText": "Boards & Beyonds：Hypertension",
                    "prevID": 105,
                    "parrentID": 105,
                    "prevsiblingID": 105
                },
                {
                    "id": 107,
                    "innerText": "心臟學會 2022 Taiwan hypertension guideline ",
                    "prevID": 106,
                    "parrentID": 106,
                    "prevsiblingID": 106
                },
                {
                    "id": 108,
                    "innerText": " https://www.tsoc.org.tw/upload/files/2022%20Taiwan%20Hypertension%20Guidelines.pdf",
                    "prevID": 107,
                    "parrentID": 107,
                    "prevsiblingID": 107
                }
            ]
        },
        {
            "id": 3,
            "Mval": 81,
            "domARY": [
                {
                    "id": 14,
                    "innerText": "高血壓是全球最常見的慢性疾病之一，影響超過13億人。",
                    "prevID": 13,
                    "parrentID": 13,
                    "prevsiblingID": null
                },
                {
                    "id": 15,
                    "innerText": "是心血管疾病、腦中風、慢性腎病的主要危險因子。",
                    "prevID": 14,
                    "parrentID": 14,
                    "prevsiblingID": 14
                },
                {
                    "id": 16,
                    "innerText": "發病率隨年齡上升，60 歲以上族群約 50% 以上罹患高血壓。",
                    "prevID": 15,
                    "parrentID": 15,
                    "prevsiblingID": 15
                },
                {
                    "id": 18,
                    "innerText": "根據國民健康署統計，台灣20歲以上人口約 25% 罹患高血壓。",
                    "prevID": 17,
                    "parrentID": 17,
                    "prevsiblingID": 16
                },
                {
                    "id": 19,
                    "innerText": "老年族群 (>65 歲) 高血壓盛行率達 70% 以上。",
                    "prevID": 18,
                    "parrentID": 18,
                    "prevsiblingID": 18
                },
                {
                    "id": 20,
                    "innerText": "控制率低，約 1/3 患者血壓未達標準。",
                    "prevID": 19,
                    "parrentID": 19,
                    "prevsiblingID": 19
                },
                {
                    "id": 29,
                    "innerText": "血壓受 心輸出量 (CO) 與總周邊阻力 (TPR) 調控，影響因素包括：",
                    "prevID": 28,
                    "parrentID": 28,
                    "prevsiblingID": 20
                },
                {
                    "id": 39,
                    "innerText": "佔95%，常發生於25-55歲，病因不明，與多基因遺傳與環境因素相關。",
                    "prevID": 38,
                    "parrentID": 38,
                    "prevsiblingID": 29
                },
                {
                    "id": 40,
                    "innerText": "主要危險因子：",
                    "prevID": 39,
                    "parrentID": 39,
                    "prevsiblingID": 39
                },
                {
                    "id": 45,
                    "innerText": " 約 5-10% 的高血壓屬於次發性，有明確的病因，若治療病因可逆轉高血壓。通常發生於年輕（< 20 歲）或老年（> 50 歲）且血壓極高者，應懷疑次發性高血壓。",
                    "prevID": 44,
                    "parrentID": 44,
                    "prevsiblingID": 40
                },
                {
                    "id": 51,
                    "innerText": "診間血壓正常，但居家血壓 偏高（>135/85 mmHg）。",
                    "prevID": 50,
                    "parrentID": 50,
                    "prevsiblingID": 45
                },
                {
                    "id": 52,
                    "innerText": "常見於年輕族群、壓力大者、糖尿病患者。",
                    "prevID": 51,
                    "parrentID": 51,
                    "prevsiblingID": 51
                },
                {
                    "id": 53,
                    "innerText": "需透過居家血壓監測或 24 小時血壓監測診斷。",
                    "prevID": 52,
                    "parrentID": 52,
                    "prevsiblingID": 52
                },
                {
                    "id": 55,
                    "innerText": "診間血壓升高，但居家血壓正常。",
                    "prevID": 54,
                    "parrentID": 54,
                    "prevsiblingID": 53
                },
                {
                    "id": 56,
                    "innerText": "可能與焦慮、交感神經亢進有關。",
                    "prevID": 55,
                    "parrentID": 55,
                    "prevsiblingID": 55
                },
                {
                    "id": 57,
                    "innerText": "若無其他心血管風險，可觀察追蹤，不一定要用藥。",
                    "prevID": 56,
                    "parrentID": 56,
                    "prevsiblingID": 56
                },
                {
                    "id": 59,
                    "innerText": "使用3種以上降壓藥（包含利尿劑），血壓仍未達標（> 140/90 mmHg）。",
                    "prevID": 58,
                    "parrentID": 58,
                    "prevsiblingID": 57
                },
                {
                    "id": 60,
                    "innerText": "需排除假性高血壓（如測量錯誤、依從性差），並考慮次發性高血壓。",
                    "prevID": 59,
                    "parrentID": 59,
                    "prevsiblingID": 59
                },
                {
                    "id": 63,
                    "innerText": "血壓受心輸出量 (CO) 與 總周邊阻力 (TPR) 調控，影響因素包括：",
                    "prevID": 62,
                    "parrentID": 62,
                    "prevsiblingID": 60
                }
            ]
        },
        {
            "id": 4,
            "Mval": 108,
            "domARY": [
                {
                    "id": 30,
                    "innerText": "交感神經系統：活化後心率加快、血管收縮，導致血壓上升。",
                    "prevID": 29,
                    "parrentID": 29,
                    "prevsiblingID": null
                },
                {
                    "id": 31,
                    "innerText": "腎素-血管收縮素-醛固酮系統 (RAAS)：",
                    "prevID": 30,
                    "parrentID": 30,
                    "prevsiblingID": 30
                },
                {
                    "id": 34,
                    "innerText": "內皮功能 (Endothelial Dysfunction)：",
                    "prevID": 33,
                    "parrentID": 33,
                    "prevsiblingID": 31
                },
                {
                    "id": 41,
                    "innerText": "家族史 (遺傳因素)",
                    "prevID": 40,
                    "parrentID": 40,
                    "prevsiblingID": 34
                },
                {
                    "id": 42,
                    "innerText": "年齡增加 (血管硬化、彈性降低)",
                    "prevID": 41,
                    "parrentID": 41,
                    "prevsiblingID": 41
                },
                {
                    "id": 43,
                    "innerText": "生活習慣 (高鈉飲食、久坐、肥胖、吸菸、過量飲酒)",
                    "prevID": 42,
                    "parrentID": 42,
                    "prevsiblingID": 42
                },
                {
                    "id": 64,
                    "innerText": "交感神經系統：活化後心率加快、血管收縮，導致血壓上升。",
                    "prevID": 63,
                    "parrentID": 63,
                    "prevsiblingID": 43
                },
                {
                    "id": 65,
                    "innerText": "腎素-血管收縮素-醛固酮系統 (RAAS)：",
                    "prevID": 64,
                    "parrentID": 64,
                    "prevsiblingID": 64
                },
                {
                    "id": 68,
                    "innerText": "內皮功能 (Endothelial Dysfunction)：",
                    "prevID": 67,
                    "parrentID": 67,
                    "prevsiblingID": 65
                }
            ]
        },
        {
            "id": 5,
            "Mval": 135,
            "domARY": [
                {
                    "id": 32,
                    "innerText": "腎素 (Renin) 促進血管收縮素 II (Angiotensin II) 生成，導致血管收縮。",
                    "prevID": 31,
                    "parrentID": 31,
                    "prevsiblingID": null
                },
                {
                    "id": 33,
                    "innerText": "醛固酮 (Aldosterone) 促進鈉水滯留，提高血容量。",
                    "prevID": 32,
                    "parrentID": 32,
                    "prevsiblingID": 32
                },
                {
                    "id": 35,
                    "innerText": "NO (一氧化氮) 減少，降低血管舒張能力。",
                    "prevID": 34,
                    "parrentID": 34,
                    "prevsiblingID": 33
                },
                {
                    "id": 36,
                    "innerText": "內皮素-1 (ET-1) 增加，促進血管收縮。",
                    "prevID": 35,
                    "parrentID": 35,
                    "prevsiblingID": 35
                },
                {
                    "id": 66,
                    "innerText": "腎素 (Renin) 促進血管收縮素 II (Angiotensin II) 生成，導致血管收縮。",
                    "prevID": 65,
                    "parrentID": 65,
                    "prevsiblingID": 36
                },
                {
                    "id": 67,
                    "innerText": "醛固酮 (Aldosterone) 促進鈉水滯留，提高血容量。",
                    "prevID": 66,
                    "parrentID": 66,
                    "prevsiblingID": 66
                },
                {
                    "id": 69,
                    "innerText": "NO (一氧化氮) 減少，降低血管舒張能力。",
                    "prevID": 68,
                    "parrentID": 68,
                    "prevsiblingID": 67
                },
                {
                    "id": 70,
                    "innerText": "內皮素-1 (ET-1) 增加，促進血管收縮。",
                    "prevID": 69,
                    "parrentID": 69,
                    "prevsiblingID": 69
                }
            ]
        },
        {
            "id": 6,
            "Mval": 9999,
            "domARY": [
                {
                    "id": 1,
                    "innerText": "",
                    "prevID": 0,
                    "parrentID": 0,
                    "prevsiblingID": null
                },
                {
                    "id": 2,
                    "innerText": "",
                    "prevID": 1,
                    "parrentID": 1,
                    "prevsiblingID": 1
                },
                {
                    "id": 3,
                    "innerText": "",
                    "prevID": 2,
                    "parrentID": 2,
                    "prevsiblingID": 2
                },
                {
                    "id": 4,
                    "innerText": "",
                    "prevID": 3,
                    "parrentID": 3,
                    "prevsiblingID": 3
                },
                {
                    "id": 5,
                    "innerText": "",
                    "prevID": 4,
                    "parrentID": 4,
                    "prevsiblingID": 4
                },
                {
                    "id": 6,
                    "innerText": "",
                    "prevID": 5,
                    "parrentID": 5,
                    "prevsiblingID": 5
                },
                {
                    "id": 7,
                    "innerText": "",
                    "prevID": 6,
                    "parrentID": 6,
                    "prevsiblingID": 6
                },
                {
                    "id": 8,
                    "innerText": "",
                    "prevID": 7,
                    "parrentID": 7,
                    "prevsiblingID": 7
                },
                {
                    "id": 9,
                    "innerText": "",
                    "prevID": 8,
                    "parrentID": 8,
                    "prevsiblingID": 8
                },
                {
                    "id": 10,
                    "innerText": "",
                    "prevID": 9,
                    "parrentID": 9,
                    "prevsiblingID": 9
                },
                {
                    "id": 11,
                    "innerText": " ",
                    "prevID": 10,
                    "parrentID": 10,
                    "prevsiblingID": 10
                },
                {
                    "id": 22,
                    "innerText": "分類\n\n\t\n\n診間血壓（mmHg）\n\n\t\n\n居家血壓（mmHg）\n\n\n\n\n正常血壓\n\n\t\n\n< 120 / 80\n\n\t\n\n< 120 / 80\n\n\n\n\n高血壓前期（Elevated BP）\n\n\t\n\n120-129 / < 80\n\n\t\n\n120-129 / < 80\n\n\n\n\n第一期高血壓（Stage 1 HTN）\n\n\t\n\n130-139 / 80-89\n\n\t\n\n130-134 / 80-84\n\n\n\n\n第二期高血壓（Stage 2 HTN）\n\n\t\n\n≥ 140 / 90\n\n\t\n\n≥ 135 / 85\n\n\n\n\n重度高血壓（Severe HTN）\n\n\t\n\n≥ 180 / 110\n\n\t\n\n-",
                    "prevID": 21,
                    "parrentID": 21,
                    "prevsiblingID": 11
                },
                {
                    "id": 23,
                    "innerText": " ",
                    "prevID": 22,
                    "parrentID": 22,
                    "prevsiblingID": 22
                },
                {
                    "id": 47,
                    "innerText": "病因分類\n\n\t\n\n疾病\n\n\t\n\n機制\n\n\t\n\n診斷方式\n\n\n\n\n腎臟疾病（Renal causes）\n\n\t\n\n腎實質疾病：慢性腎衰竭CKD患者約 80% 會有高血壓\n\n\t\n\n腎小球濾過率降低，RAAS 活化\n\n\t\n\nActive Urine Sediment、蛋白尿 >1000 mg/d\n\n\n\n\n \n\n\t\n\n腎動脈狹窄（Renal artery stenosis）：\n\n1. 動脈粥樣硬化（Atherosclerosis）佔 90%\n\n2. 纖維肌發育不良（Fibromuscular Dysplasia）佔 10%，好發於年輕女性，雙側（Bilateral），且多影響腎動脈較遠端的區域（Distal Renal Artery）。\n\n \n\n\t\n\n狹窄導致腎臟的灌流壓下降，啟動RAAS，angiotensin II 導致血管收縮\n\n\t\n\n腎血流掃描（Renal Scintigraphy）、都卜勒超音波\n\n、MRA、腎動脈造影（Renal Angiography, Gold Standard）\n\n\n\n\n內分泌疾病（Endocrine causes）\n\n\t\n\n原發性醛固酮增多症（Primary Aldosteronism, Conn's Syndrome）\n\n\t\n\n醛固酮過多，鈉滯留、鉀流失\n\n\t\n\n血漿Aldosterone & Renin ratio\n\n\n\n\n \n\n\t\n\n庫欣氏症（Cushing’s syndrome）\n\n\t\n\n皮質醇過多，水鈉滯留\n\n\t\n\n24hr 尿 Cortisol、Dexamethasone suppression test\n\n\n\n\n \n\n\t\n\n嗜鉻細胞瘤（Pheochromocytoma）\n\n\t\n\n兒茶酚胺過多，交感神經興奮\n\n\t\n\n24hr 尿 Metanephrines\n\n\n\n\n \n\n\t\n\n甲狀腺疾病（Thyroid dysfunction）\n\n\t\n\n甲狀腺功能異常影響心血管\n\n\t\n\nTSH, T3, T4\n\n\n\n\n血管疾病（Vascular causes）\n\n\t\n\n主動脈縮窄（Coarctation of the aorta）\n\n\t\n\n主動脈狹窄，導致上半身高血壓\n\n\t\n\nCXR, CTA, MRI\n\n\n\n\n神經性高血壓（Neurologic causes）\n\n\t\n\n顱內壓升高（如腦瘤、腦出血）\n\n\t\n\n影響交感神經\n\n\t\n\n腦部影像（CT, MRI）\n\n\n\n\n藥物與毒物（Drug-induced）\n\n\t\n\nNSAIDs、類固醇、口服避孕藥、抗憂鬱藥\n\n\t\n\n影響鈉水滯留或血管收縮\n\n\t\n\n病史詢問\n\n\n\n\n \n\n\t\n\n交感神經興奮藥物（Cocaine, 安非他命）\n\n\t\n\n交感神經興奮\n\n\t\n\n毒物篩檢",
                    "prevID": 46,
                    "parrentID": 46,
                    "prevsiblingID": 23
                },
                {
                    "id": 71,
                    "innerText": " ",
                    "prevID": 70,
                    "parrentID": 70,
                    "prevsiblingID": 47
                },
                {
                    "id": 73,
                    "innerText": "併發症\n\n\t\n\n機制與影響\n\n\n\n\n中風（Stroke）\n\n\t\n\n高血壓是缺血性中風（Ischemic stroke） 和出血性中風（Hemorrhagic stroke）的最重要危險因子。\n- 缺血性中風：動脈硬化導致腦部血管狹窄、血栓形成。\n- 出血性中風：長期高血壓導致小動脈破裂，特別是在基底核（Basal ganglia）\n\n\n\n\n心臟病（Heart Disease） \n\n\t\n\n高血壓增加心臟負擔，造成心肌肥厚、供血不足，引起心臟病。\n\n\n\n\n心肌梗塞（Myocardial Infarction, MI）\n\n\t\n\n高血壓加速動脈硬化，導致冠狀動脈阻塞，造成心肌壞死。\n\n\n\n\n心臟衰竭（Heart Failure, HF）\n\n\t\n\n高血壓導致左心室肥厚（LVH），心臟無法有效收縮或舒張，造成收縮性或舒張性心衰竭。\n\n\n\n\n腎衰竭（Renal Failure）\n\n\t\n\n高血壓損害腎臟小動脈，造成腎絲球硬化（Glomerulosclerosis），影響腎臟功能，導致慢性腎病（CKD） 或 腎衰竭（ESRD）。\n\n\n\n\n主動脈瘤（Aortic Aneurysm）\n\n\t\n\n高血壓造成動脈壁壓力升高，導致動脈擴張，特別是腹主動脈瘤（AAA, Abdominal Aortic Aneurysm）。\n\n\n\n\n主動脈剝離（Aortic Dissection）\n\n\t\n\n高血壓會加速動脈硬化與彈性降低，當血壓過高時，可能導致主動脈內膜破裂，形成主動脈夾層（Aortic dissection），是致命的急症。",
                    "prevID": 72,
                    "parrentID": 72,
                    "prevsiblingID": 71
                },
                {
                    "id": 74,
                    "innerText": " ",
                    "prevID": 73,
                    "parrentID": 73,
                    "prevsiblingID": 73
                },
                {
                    "id": 76,
                    "innerText": "類別\n\n\t\n\n定義\n\n\t\n\n治療策略\n\n\n\n\nUrgency\n\n\t\n\nBP > 180/120, 無器官損害\n\n\t\n\n口服降壓藥 (CCB, ACEI, ARB)\n\n數小時內緩慢降壓，避免過快降壓導致器官低灌流\n\n \n\n\n\n\nEmergency\n\n\t\n\nBP > 180/120, 合併器官損害\n\n\t\n\n需立即降壓（IV Nicardipine, Labetalol）靜脈注射降壓藥，2 小時內逐步降低，平均動脈壓（MAP）不超過 25-30%，目標 <160/100 mmHg\n\n ",
                    "prevID": 75,
                    "parrentID": 75,
                    "prevsiblingID": 74
                },
                {
                    "id": 79,
                    "innerText": "族群\n\n\t\n\n目標血壓（mmHg）\n\n\n\n\n一般成人（< 65 歲）\n\n\t\n\n< 130/80\n\n\n\n\n老年人（≥ 65 歲）\n\n\t\n\n< 140/90（若可耐受可達 < 130/80）\n\n\n\n\n慢性腎病（CKD）、糖尿病（DM）、冠心病（CAD）\n\n\t\n\n< 130/80\n\n\n\n\n高危險族群（已發生中風、心肌梗塞）\n\n\t\n\n< 130/80",
                    "prevID": 78,
                    "parrentID": 78,
                    "prevsiblingID": 76
                },
                {
                    "id": 84,
                    "innerText": "方式\n\n\t\n\n降壓效果\n\n\n\n\n體重控制\n\n\t\n\nBMI<25 kg/m2\n\n\n\n\nDASH 飲食\n\n\t\n\n低鈉、高鉀、高纖\n\n\n\n\n鈉攝取控制\n\n\t\n\n<6 g NaCl/日\n\n\n\n\n規律運動\n\n\t\n\n每週 150 分鐘中等強度運動\n\n\n\n\n限制酒精攝取\n\n\t\n\n男性 < 2 杯/日，女性 < 1 杯/日",
                    "prevID": 83,
                    "parrentID": 83,
                    "prevsiblingID": 79
                },
                {
                    "id": 85,
                    "innerText": " ",
                    "prevID": 84,
                    "parrentID": 84,
                    "prevsiblingID": 84
                },
                {
                    "id": 88,
                    "innerText": "藥物類別\n\n\t\n\n代表藥物\n\n\t\n\n機制\n\n\t\n\n適應症\n\n\t\n\n主要副作用\n\n\n\n\n利尿劑(Diuretics)\n\n\t\n\nThiazides: Hydrochlorothiazide, Chlorthalidone；Loop: Furosemide\n\n\t\n\n減少鈉水滯留，降低血容量\n\n\t\n\n輕中度高血壓，合併心衰、CKD\n\n\t\n\n低血鉀（Thiazides）、低血鈉、高尿酸\n\n\n\n\nACE 抑制劑(ACEi)\n\n\t\n\nEnalapril, Lisinopril, Ramipril\n\n\t\n\n抑制 Angiotensin II 生成，降低血管收縮與醛固酮分泌\n\n\t\n\n糖尿病腎病、心衰、冠心病（CHD）\n\n對腎，心血管有保護作用\n\n\t\n\n乾咳、高血鉀、腎功能惡化（特別是 RAS 狹窄者）\n\n\n\n\nARB(Angiotensin II 受體阻斷劑)\n\n\t\n\nLosartan, Valsartan, Olmesartan\n\n\t\n\n阻斷 Angiotensin II 受體\n\n\t\n\nACEi 無法耐受者，糖尿病腎病\n\n\t\n\n高血鉀、腎功能惡化（RAS 狹窄）\n\n\n\n\n鈣通道阻斷劑（CCBs）\n\n\t\n\nDihydropyridine: Amlodipine, Nifedipine；Non-DHP: Diltiazem, Verapamil\n\n\t\n\nDHP: 血管擴張，Non-DHP: 降低心臟收縮力\n\n\t\n\nDHP: 高血壓，Non-DHP: 心律不整\n\n\t\n\nDHP: 下肢水腫，Non-DHP: 心搏過慢",
                    "prevID": 87,
                    "parrentID": 87,
                    "prevsiblingID": 85
                },
                {
                    "id": 90,
                    "innerText": "β 阻斷劑（Beta-Blockers）\n\n\t\n\nMetoprolol, Atenolol, Carvedilol\n\n\t\n\n降低心輸出量，減少交感神經活性\n\n\t\n\n心絞痛、心衰、主動脈剝離\n\n\t\n\n心搏過慢、疲勞、勃起功能障礙\n\n\n\n\nα, β 雙重阻斷劑\n\n\t\n\nLabetalol, Carvedilol\n\n\t\n\n同時阻斷 α、β 受體，擴張血管\n\n\t\n\n妊娠期高血壓、主動脈剝離\n\n\t\n\n低血壓、疲勞、眩暈\n\n\n\n\n直接血管擴張劑\n\n\t\n\nHydralazine, Minoxidil\n\n\t\n\n直接作用於小動脈\n\n\t\n\n主要用於頑固性高血壓\n\n\t\n\n反射性心搏過速，水腫\n\n\n\n\n醛固酮拮抗劑\n\n\t\n\nSpironolactone, Eplerenone\n\n\t\n\n拮抗醛固酮，保鉀利尿\n\n\t\n\n主要用於耐藥性高血壓\n\n\t\n\n高血鉀、男性女乳症（Spironolactone）",
                    "prevID": 89,
                    "parrentID": 89,
                    "prevsiblingID": 88
                },
                {
                    "id": 97,
                    "innerText": "藥物\n\n\t\n\n機制\n\n\t\n\n適應症\n\n\t\n\n主要副作用\n\n\n\n\nHydralazine\n\n\t\n\n動脈擴張劑\n\n\t\n\n妊娠相關高血壓（如子癇前症）\n\n\t\n\n低血壓、反射性心跳過快、頭痛、面部潮紅\n\n\n\n\nEsmolol\n\n\t\n\nβ1 選擇性阻斷劑\n\n\t\n\n主動脈剝離\n\n\t\n\n低血壓、心跳過慢、心律不整、呼吸困難\n\n\n\n\nNitroprusside\n\n\t\n\n一氧化氮供應劑，擴張動靜脈\n\n\t\n\n急性心衰、主動脈剝離，但 慎防氰化物中毒\n\n\t\n\n氰化物中毒、低血壓、反射性心跳過快\n\n\n\n\nLabetalol\n\n\t\n\nα、β 雙重阻斷劑\n\n\t\n\n急性高血壓，常用於妊娠期\n\n\t\n\n低血壓、心跳過慢、疲倦、頭暈、呼吸困難\n\n\n\n\nClevidipine / Nicardipine\n\n\t\n\n鈣離子通道阻斷劑（Dihydropyridine 類）\n\n\t\n\n最常用於高血壓危象，可控性佳\n\n\t\n\n低血壓、頭暈、反射性心跳過快、浮腫、頭痛",
                    "prevID": 96,
                    "parrentID": 96,
                    "prevsiblingID": 90
                },
                {
                    "id": 109,
                    "innerText": " ",
                    "prevID": 108,
                    "parrentID": 108,
                    "prevsiblingID": 97
                }
            ]
        }
    ]
}